Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study.

Autor: Özyurt N; Department of Medical Oncology, Ordu University School of Medicine, Ordu, Turkey., Alkan A; Department of Medical Oncology, Muğla Sıtkı Koçman University School of Medicine, Muğla, Turkey. alkanali@yahoo.com.; Faculty of Medicine, Department of Medical Ongology, Mugla Sıtkı Koçman University, Kötekli Mh. Marmaris Yolu Bulvarı No: 55 Menteşe, Muğla, 48000, Turkey. alkanali@yahoo.com., Gülbağcı B; Department of Medical Oncology, Sakarya University School of Medicine, Sakarya, Turkey., Seyyar M; Department of Medical Oncology, Kocaeli University School of Medicine, İzmit, Turkey., Aydın E; Department of Medical Oncology, Karadeniz Technical University School of Medicine, Trabzon, Turkey., Şahbazlar M; Department of Medical Oncology, Celal Bayar University School of Medicine, Manisa, Turkey., Türker M; Department of Medical Oncology, Çukurova University School of Medicine, Adana, Turkey., Kınıkoğlu O; Department of Medical Oncology, Kartal Training and Research Hospital, İstanbul, Turkey., Yerlikaya T; Department of Medical Oncology, Antalya Training and Research Hospital, Antalya, Turkey., Dinç G; Department of Medical Oncology, Okmeydanı Training and Research Hospital, İstanbul, Turkey., Aytaç A; Department of Medical Oncology, Aydın Adnan Menderes University School of Medicine, Aydın, Turkey., Kalkan Z; Department of Medical Oncology, Dicle University School of Medicine, Diyarbakır, Turkey., Ebinç S; Diyarbakır Training and Research Hospital, Department of Medical Oncology, Diyarbakır, Turkey., Gültürk İ; Department of Medical Oncology, Bakırköy Sadi Konuk Training and Research Hospital, İstanbul, Turkey., Keskinkılıç M; Department of Medical Oncology, Dokuz Eylül University School of Medicine, İzmir, Turkey., İşleyen ZS; Department of Medical Oncology, Bezm-i Alem Vakıf University School of Medicine, İstanbul, Turkey., Çağlayan D; Department of Medical Oncology, Necmettin Erbakan University School of Medicine, Konya, Turkey., Türkel A; Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey., Aydın E; Department of Medical Oncology, Recep Tayyip Erdoğan University School of Medicine, Rize, Turkey., Şakalar T; Department of Medical Oncology, Kahramanmaraş Necip Fazıl City Hospital, Kahramanmaraş, Turkey., Sekmek S; Ankara Bilkent City Hospital, Department of Medical Oncology, Ankara, Turkey., Yıldırım N; Department of Medical Oncology, Fırat University School of Medicine, Elazığ, Turkey., Koçak S; Department of Medical Oncology, Koç University School of Medicine, İstanbul, Turkey., Okutur K; Department of Medical Oncology, İstanbul Arel University School of Medicine, İstanbul, Turkey., Özveren A; Department of Medical Oncology, Acıbadem Kent Hospital, İzmir, Turkey., Dursun B; Department of Medical Oncology, Ankara University School of Medicine, Ankara, Turkey., Kitaplı S; Department of Medical Oncology, Muğla Sıtkı Koçman University School of Medicine, Muğla, Turkey., Eren OÖ; Department of Medical Oncology, Selçuk University School of Medicine, Konya, Turkey., Beypınar İ; Department of Medical Oncology, Alanya Alaittin Keykubat University School of Medicine, Antalya, Turkey., Hacıbekiroğlu İ; Department of Medical Oncology, Sakarya University School of Medicine, Sakarya, Turkey., Çabuk D; Department of Medical Oncology, Kocaeli University School of Medicine, İzmit, Turkey., Karaman E; Department of Medical Oncology, Karadeniz Technical University School of Medicine, Trabzon, Turkey., Acar Ö; Department of Medical Oncology, Celal Bayar University School of Medicine, Manisa, Turkey., Paydaş S; Department of Medical Oncology, Çukurova University School of Medicine, Adana, Turkey., Eryılmaz MK; Department of Medical Oncology, Necmettin Erbakan University School of Medicine, Konya, Turkey., Demir B; Department of Medical Oncology, Aydın Adnan Menderes University School of Medicine, Aydın, Turkey., Oruç Z; Department of Medical Oncology, Dicle University School of Medicine, Diyarbakır, Turkey., Yılmaz M; Department of Medical Oncology, Bakırköy Sadi Konuk Training and Research Hospital, İstanbul, Turkey., Biricik FS; Department of Medical Oncology, Koç University School of Medicine, İstanbul, Turkey., Salim DK; Department of Medical Oncology, Antalya Training and Research Hospital, Antalya, Turkey., Tanrıverdi Ö; Department of Medical Oncology, Muğla Sıtkı Koçman University School of Medicine, Muğla, Turkey., Doğan M; Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey.

Publikováno v: Scientific reports [Sci Rep] 2024 Oct 09; Vol. 14 (1), pp. 23556. Date of Electronic Publication: 2024 Oct 09.

Comparison of prognostic value of different metabolic response criteria determined by PET/CT in patients with metastatic breast cancer under CDK 4/6 inhibitor treatment.

Autor: Önner H; Department of Nuclear Medicine, Medical Faculty, Selcuk University, Konya, Turkey. Electronic address: hasanonner@gmail.com., Eren OÖ; Department of Medical Oncology, Medical Faculty, Selcuk University, Konya, Turkey., Körez MK; Department of Biostatistics, Medical Faculty, Selcuk University, Konya, Turkey., Yilmaz F; Department of Nuclear Medicine, Medical Faculty, Selcuk University, Konya, Turkey., Kara Gedik G; Department of Nuclear Medicine, Medical Faculty, Selcuk University, Konya, Turkey.

Publikováno v: Revista espanola de medicina nuclear e imagen molecular [Rev Esp Med Nucl Imagen Mol (Engl Ed)] 2023 Sep-Oct; Vol. 42 (5), pp. 319-324. Date of Electronic Publication: 2023 Apr 06.